Nitrosamine Drug-Substance-Related Impurities (NDSRIs) in Pharmaceuticals: Formation Chemistry, Mechanistic Pathways, Analytical Characterization, Risk Assessment, Mitigation Strategies and Regulatory Perspectives
Year: 2026
Type: article
Abstract: Nitrosamine drug-substance-related impurities (NDSRIs) have emerged as a distinctive pharmaceutical-quality challenge because their formation is governed by an intersection of drug-substance structure, nitrosating chemistry, formulation composition, manufacturing conditions, storage environment, and degradation pathways. Unlike several low-molecular-weight nitrosamines that can occur across multiple products, NDSRIs are structurally related to individual active pharmaceutical ingredients (APIs), making their identities, formation mechanisms, analytical behavior, and toxicological profiles substantially more heterogeneous. This review critically examines the chemistry underlying NDSRI formation, with emphasis on nitrosation of secondary and selected tertiary amine functionalities, the influence of pH, nitrite availability, microenvironment, excipients, water activity, temperature, solid-state properties, and degradation chemistry. Contemporary analytical strategies based on liquid chromatography–tandem mass spectrometry, high-resolution mass spectrometry, gas chromatography–mass spectrometry, targeted and non-targeted workflows, and orthogonal structural confirmation are evaluated in relation to sensitivity, selectivity, matrix effects, method complexity, and regulatory fitness. Toxicological assessment is considered through mutagenicity, metabolic activation, structure–activity relationships, carcinogenic potency categorization, read-across, and emerging mechanistic approaches. Particular attention is given to the evolution of acceptable-intake frameworks and the increasing convergence of chemistry, analytical science, toxicology, quality risk management, and regulatory decision-making. Emerging QSAR, graph-based machine learning, chemometrics, and computational chemistry approaches are critically assessed, emphasizing that prediction of nitrosation susceptibility is not equivalent to prediction of actual impurity formation or toxicological risk. Industrial mitigation strategies spanning synthetic-route design, excipient control, formulation engineering, process optimization, packaging, storage, and lifecycle monitoring are compared. Finally, future opportunities involving high-resolution non-targeted analysis, automated laboratories, predictive quality systems, digital process monitoring, and mechanistically constrained artificial intelligence are identified. The review highlights the need for harmonized datasets, experimentally anchored prediction, transparent model validation, and integrated lifecycle control strategies to move NDSRI management from reactive detection toward proactive prevention.
Source: IJPAR JOURNAL
Institution: Chaitanya
Language: English
Subfield: Analytical Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: hybrid
OpenAlex ID: W7214362355
